POMC and cancer: The Society for Immunotherapy of Cancer (SITC) Toxicity Management guidelines recommend checking baseline morning cortisol and ACTH levels before starting treatment, followed by monthly monitoring for 6 months, then every 3 months for 6 months, and every 6 months for 1 year thereafter [15].